How COVID-19 Has Changed The eCOA/ePRO Landscape
Source: YPrime
The coronavirus (COVID-19) pandemic has had a profound impact on families, communities, industries, and economies and that impact may be felt for years. The disruption caused by it has necessitated significant changes to the way we work and live. Dorothy Brown interviews Donna Mongiello as they discuss how to adapt to crises that impact the industry and speed up the adoption of technological tools to meet current and long-term needs. Despite the pain and disruption that this pandemic has created, it has enabled an opportunity for drug developers to explore new patient-facing technologies. Watch the webinar to learn more.
VIEW THE WEBINAR!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.
Subscribe to Clinical Leader
X
Subscribe to Clinical Leader
YPrime
This website uses cookies to ensure you get the best experience on our website. Learn more